c hicago gyn oncology updates
TRANSCRIPT
FRIDAY, MAY 14, 2021INAUGURAL MEETING: VIRTUAL FORMAT
COURSE DIRECTORSGINI FLEMING, MD | UNIVERSITY OF CHICAGO MEDICINEDIANE YAMADA, MD | UNIVERSITY OF CHICAGO MEDICINEKATHERINE KURNIT, MD, MPH | UNIVERSITY OF CHICAGO MEDICINE
C H I C A G OGYN ONCOLOGY
U P D A T E S
LEARNING OBJECTIVESAt the conclusion of this activity, participants will be able to:
·· Define the mechanisms of action and side effect profiles of new gynecologic cancer therapies;
·· Discuss how to apply recent PARP inhibitor research to front-line therapy of ovarian cancer;
·· Describe how to select ovarian cancer patients for maintenance therapy with PARP inhibitors and for antiangiogenic therapy;
·· Identify strategies to explain to patients the efficacy results of immunotherapy and immunotherapy/antiangiogenic combination therapy in endometrial cancer;
·· Determine the sequencing and combination of new agents used for gynecologic cancer care with current therapies;
·· Identify contextual barriers to the integration of new gynecologic cancer agents into patient care;
·· Recall how to overcome barriers to recruit underserved populations for clinical trials;
·· Select appropriate tumor genomic tests for gynecologic cancer patients.
TARGET AUDIENCEThis activity is designed for gynecologic oncologists, medical oncologists, radiation oncologists, gynecologists, trainees, research scientists, nurses, nurse practitioners, physician assistants, and other healthcare professionals dedicated to the care of patients with gynecologic malignancies.
PHYSICIAN CREDITThe University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING CREDITUniversity of Chicago Medicine is approved as a provider of nursing continuing professional development by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
This live activity is designated for a maximum of 3.25 continuing nursing education units.
AMERICAN BOARD OF INTERNAL MEDICINE MOC PART II CREDITSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
OTHER HEALTHCARE PROFESSIONALS CREDITOther healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
COURSE DESCRIPTION
Chicago GYN Oncology Updates will celebrate contributions of SGO members, providing
access to the most important educational and scientific updates for women’s healthcare
professionals from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s
Cancer. This conference will include information and resources for members of the entire
gynecologic cancer care team who provide treatment and care in the areas of chemotherapy,
radiation therapy, and surgery. This highly interactive program will provide participants with
distillations of advances in the fields of ovarian cancer and endometrial cancer. Topics will
include both appropriate use of new therapies including immunotherapy, antiangiogenic
agents, and PARP inhibitors, as well as information on appropriate use and applications of
genomic testing. In addition, the critical importance of clinical research will be highlighted
with presentations of Chicago area investigator-initiated trials and information regarding the
importance of and suggestions for inclusion of underserved populations in clinical research.
INFORMATION
FACULTY
COURSE DIRECTORSGini Fleming, MD Professor of Medicine
Medical Oncology Director,
Gynecologic Oncology
University of Chicago
Diane Yamada, MD Joseph Bolivar DeLee Professor
of Obstetrics and Gynecology
Chief, Section of
Gynecologic Oncology
University of Chicago
Katherine Kurnit, MD, MPH Assistant Professor of
Obstetrics and Gynecology
University of Chicago
KEYNOTE SPEAKERSMichael Bookman, MD Director, Gynecologic
Oncology Therapeutics
Kaiser Permanente
Matthew Powell, MD Professor
Obstetrics and Gynecology
Chief, Division of
Gynecologic Oncology
Washington University St. Louis
CONFERENCE FACULTY
Amina Ahmed, MD
Director, Cancer Service Line
Associate Professor
Department of OBGYN, Division
Gynecologic Oncology
Rush University Medical Center
Raanan Alter, MD
Gynecologic Oncology Fellow
University of Chicago
Emma Barber, MD, MS
Assistant Professor of
Obstetrics and Gynecology
(Gynecologic Oncology)
Northwestern University
Amanda Nickles Fader, MD
Vice Chair of Gynecologic
Surgical Operations
Associate Professor of
Gynecology and Obstetrics
Johns Hopkins Health System
Yasmin Hasan, MD
Associate Professor
Director of Gynecological
Brachytherapy
Residency Program Director
Department of Radiation and
Cellular Oncology at UCMC
Josephine Kim, MD
Assistant Professor
Department of Obstetrics
and Gynecology
University of Chicago
Ricardo Lastra, MD
Associate Professor of
Pathology
University of Chicago
Nita Lee, MD, MPH
Associate Professor of
Obstetrics and Gynecology
University of Chicago
Ernst Lengyel, MD, PhD
Arthur L. and Lee G Herbst
Professor of Obstetrics
and Gynecology
Chair, Department of
Obstetrics and Gynecology
University of Chicago
Daniela Matei, MD
Diana, Princess of Wales
Professor of Cancer Research
Professor of Medicine
(Hematology and Oncology)
And Obstetrics and Gynecology
(Gynecologic Oncology)
Northwestern University
Kathryn Mills, MD
Assistant Professor
Department of
Obstetrics & Gynecology
University of Chicago
John Moroney, MD
Associate Professor of
Obstetrics and Gynecology
University of Chicago
Kunle Odunsi, MD, PhD
Professor of Obstetrics
and Gynecology
BSD Dean for Oncology
Director of the University of
Chicago Comprehensive
Cancer Center
Blase Polite, MD
Professor of Medicine
University of Chicago
William Small, MD
Professor
Department Chairperson,
Radiation Oncology
Loyola University
Christina Son, MD
Assistant Professor
Department of Radiation and
Cellular Oncology
University of Chicago
Lydia Usha, MD
Professor of Medicine
Hematology, Oncology,
And Cell Therapy
Rush University Cancer Center
Tilley Jenkins Vogel, MD
Clinical Assistant Professor
NorthShore University
HealthSystem
University of Chicago
cme.uchicago.edu/GynOncUpdates2021
FRIDAY, MAY 14, 2021
8:00 am Introduction of Diane Yamada,
SGO President
Ernst Lengyel, MD, PhD
8:05 am WELCOME
Diane Yamada, MD
Kunle Odunsi, MD, PhD
FIRST HALF MODERATORS:
Katherine Kurnit, MD, MPH &
Josephine Kim, MD
OVARIAN CANCER
8:10 am Tumor Board Presentation
Raanan Alter, MD
Ricardo Lastra, MD
8:25 am Emerging Landscape in Front-
line Therapy of Ovarian Cancer
Michael Bookman, MD
8:50 am SGO Abstract Review:
Ovarian Cancer
Kathryn Mills, MD
9:10 am Q&A
WHIRLWIND TOUR OF IITs
IN THE CITY – PART A
9:20 am Metformin for Ovarian Cancer
Diane Yamada, MD
9:25 am Surgery for Older Women
with Ovarian Cancer
Amina Ahmed, MD
9:30 am Folate Repletion and
PARPi Therapy
Lydia Usha, MD
9:35 am Guadecitabine/Pembro
for Ovarian Cancer
Daniela Matei, MD
9:40 am NETWORKING
SECOND HALF MODERATORS:
John Moroney, MD & Yasmin Hasan, MD
ENDOMETRIAL CANCER
10:10 am Changing Landscape in
Therapy of Non-metastatic
Endometrial Cancer
Matthew Powell, MD
10:35 am SGO Abstract Review:
Endometrial Cancer
Tilley Jenkins Vogel, MD
WHIRLWIND TOUR OF IITs
IN THE CITY – PART B
10:45 am Exercise and Physical Activity
Interventions in Ovarian and
Endometrial Cancer
Nita Lee, MD, MPH
10:50 am Neoadjuvant Palbo/Letrozole
in Endometrial Cancer
Emma Barber, MD, MS
10:55 am Hypofractionation for
Cervical Cancer
Christina Son, MD
11:00 am Overcoming Barriers to Trial
Accrual for Underserved
Blase Polite, MD
CERVICAL CANCER/RARE TUMORS
11:10 am SGO Abstract Review:
Cervical Cancer
William Small, MD
11:30 am SGO Abstract Review:
Rare GYN Tumors
Amanda Nickles Fader, MD
11:50 am Q&A
12:00 pm NETWORKING
AGENDA
cme.uchicago.edu/GynOncUpdates2021
REGISTRATION FEE
PHYSICIANS o $50
OTHER HEALTHCARE o $30 PROFESSIONALS
RESIDENTS AND o $30 FELLOWS
INDUSTRY o $50
PATIENT REGISTRATION: COMPLIMENTARY - Reach out to [email protected]
HOW TO REGISTER ONLINE – (credit card payment only)
cme.uchicago.edu/GynOncUpdates2021
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a 50% administrative fee will be refunded when written notification is received by April 14, 2021. No refunds will be made after April 14, 2021.
ADDITIONAL INFORMATION For information regarding course, contact [email protected].
REGISTRATION
cme.uchicago.edu/GynOncUpdates2021
DISCLOSURE DECLARATIONSAs a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks
everyone who is in a position to control the content of an education activity to disclose all relevant
financial relationships with any commercial interest. This includes any entity producing, marketing,
re-selling, or distributing health care goods or services consumed by or used on patients.
The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring
within the past 12 months, including financial relationships of a spouse or life partner that could create a
conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior
to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify
investigational products or off-label uses of products regulated by the US Food and Drug Administration,
at first mention and where appropriate in the content.
Th
e U
niv
ers
ity o
f C
hic
ag
oC
en
ter
for
Co
nti
nu
ing
Me
dic
al E
du
ca
tio
n5
84
1 S
. M
ary
lan
d A
ve
., M
C 1
137
Ch
ica
go
, IL
60
63
7
Fo
llo
w u
s o
n T
wit
ter:
@U
Ch
ica
go
CM
E
FR
IDA
Y,
MA
Y 1
4,
20
21
INA
UG
UR
AL
ME
ET
ING
: V
IRT
UA
L F
OR
MA
T